Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initiation and Titration of Guideline Directed Medical Therapy in Heart Failure Cardiogenic Shock With Impella 5.5 for Cardiac Recovery: INTeGRATE

NCT06965504 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT06965504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06965504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initiation and Titration of Guideline Directed Medical Therapy in Heart Failure Cardiogenic Shock With Impella 5.5 for Cardiac Recovery: INTeGRATE
Lead sponsor
Abiomed Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
October 2, 2026
Completion date
June 1, 2029
Enrollment
250 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, heart failure, reduced ejection fraction heart failure